CRWD enters the back half of September carrying the weight of a 7% slide over the past month — a sharp reversal after a blowout August earnings print that sent the stock 23% higher in a single day.
The tension this week is straightforward: short sellers rebuilt positions modestly into that post-earnings strength, the stock has since given back ground, and the Street's freshly lifted price targets now sit comfortably above where shares are trading. Whether that gap closes upward or continues to compress is the question defining the setup.
Short interest at just under 10% of free float is meaningful but not extreme — and crucially, the direction of travel matters more than the level here. Shorts peaked near 10.9% of float in early August, fell through the end of the month as the stock rallied hard on earnings, then nudged back up roughly 2.3% on the week to 9.95% of float. That partial rebuild signals bears stepping back in cautiously rather than capitulating. The borrow market offers them little friction: availability is essentially unlimited, and cost-to-borrow runs at just 0.41% — among the cheapest in the sector. No squeeze dynamics are present. Options positioning tells a similarly calm story. The put/call ratio of 0.96 is fractionally below its 20-day average of 0.96, with a z-score of -0.86 — well within normal range and nowhere near the defensive posturing that would signal genuine investor anxiety. The next earnings date sits on November 24, leaving plenty of runway before the options market has reason to get charged up.
The Street is broadly constructive, and recent analyst activity confirms it. Multiple firms lifted targets in the days following the August 26 earnings release. Scotiabank raised its target to $265, Raymond James moved to $250, and Roth Capital upgraded its target from $200 to $220. On September 11, Wedbush initiated with an Outperform and a $250 target — putting fresh institutional endorsement on the stock even as it drifts lower. The lone holdout in recent activity is Macquarie, which maintained a Neutral rating and a $200 target, essentially flagging the current price as fair value. With the consensus mean target at $231.54 against a close of $206.74, the implied return of roughly 12% looks reasonable — but it assumes the post-earnings momentum story doesn't continue to fade. Bulls point to CrowdStrike's AI-native platform, its $10 billion ARR target by FY30, and the recent AIDRv1.0 launch. Bears flag the lofty valuation — a trailing P/E above 139 and EV/EBITDA near 94 — alongside execution risk and growing competition in the agentic AI security space. The EV/EBITDA multiple has eased about 7 points over the past 30 days, consistent with the stock's pullback, though the forward earnings momentum score of 95th percentile suggests analysts see the growth case as intact.
Institutional flows add a layer of interest. FMR (Fidelity) added nearly 16.9 million shares in its most recent reported period, making it one of the more aggressive incremental buyers among top holders. JP Morgan Asset Management similarly added 14.2 million shares. Both moves suggest active-manager conviction even as the stock consolidates post-earnings. On the other side, early-stage backer Accel Management trimmed roughly 1 million shares — a pattern consistent with gradual monetisation of a long-held position rather than a change in view on the business.
CEO George Kurtz sold approximately $3.3 million in shares across September 4 and 8 under a pre-arranged 10b5-1 plan. These are scheduled sales, not discretionary — the plan structure strips out the directional signal that a spontaneous insider sale would otherwise carry. The low significance scores attached to each transaction (all rated 2 out of 10) reflect that interpretation.
The setup heading into the next few weeks is one of consolidation after a strong catalyst, with bulls and bears anchored to very different reference points — the August 26 earnings gap versus the six-month drift that preceded it. The next hard data point to watch is the November 24 earnings date, but near-term attention will focus on any acceleration in short rebuilding and whether analyst target upgrades attract renewed institutional flows at current levels or simply provide a floor that slows further selling.
See the live data behind this article on ORTEX.
Open CRWD on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
